ZPHC Tirzepatide – 25mg (Dual GIP/GLP-1 Agonist)
Tirzepatide 25mg from ZPHC (Zhengzhou Pharmaceutical Co.) is a high-strength dual GIP/GLP-1 receptor agonist, one of the most powerful peptides for appetite reduction and metabolic support.
Tirzepatide engages two metabolic pathways simultaneously:
🔹 GLP-1 receptor activation
-
Supports strong appetite suppression
-
Helps reduce cravings
-
Promotes a sense of fullness after meals
🔹 GIP receptor activation
-
Enhances metabolic efficiency
-
Supports improved insulin sensitivity
-
Helps regulate caloric balance
This dual mechanism results in significantly stronger effects than single-pathway GLP-1 analogues such as Semaglutide.
At 25mg, this ZPHC formulation is among the highest-strength versions available, favored in advanced weight-management settings where strong satiety and metabolic support are desired.
ZPHC is globally recognized for pharmaceutical-grade purity, consistency, and strict lab manufacturing standards, making their Tirzepatide one of the most trusted high-dosage options.
Key Benefits
- Extremely strong appetite-suppression support
- Dual-agonist action (GIP + GLP-1)
- Helps reduce overeating and cravings
- Promotes enhanced fullness and satisfaction after meals
- Supports improved metabolic balance
- Ultra-high-strength 25mg vial
- Premium ZPHC pharmaceutical quality
